Skip to main content
. 2024 Dec 9;9:345. doi: 10.1038/s41392-024-02047-0

Fig. 2.

Fig. 2

Comparison of mutation profiles in HER2-low MBC across different HR status or molecular subtypes. a Differential frequencies of gene mutations between HR-positive and HR-negative HER2-low MBC. b, c Differential gene mutation frequencies between luminal breast cancer and TNBC in the context of HER2-0 and HER2-low groups. *P < 0.05